Literature DB >> 17457345

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

Laurent Coscoy1.   

Abstract

To efficiently establish a persistent infection, Kaposi's sarcoma-associated herpesvirus (KSHV; also known as HHV8) dedicates a large amount of its coding potential to produce proteins that antagonize the immune system of its host. These viral immunomodulators interfere with both the innate and adaptive immune responses and most of them are homologous to cellular proteins, suggesting that they have been pirated from the host during viral evolution. In this Review, I present recent advances in the understanding of immune evasion by KSHV, with a particular focus on the virally encoded modulators of immune responses that are unique to this virus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457345     DOI: 10.1038/nri2076

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  78 in total

Review 1.  Cytokine homologs of human gammaherpesviruses.

Authors:  Sang-Hoon Sin; Dirk P Dittmer
Journal:  J Interferon Cytokine Res       Date:  2011-12-05       Impact factor: 2.607

2.  The intertransmembrane region of Kaposi's sarcoma-associated herpesvirus modulator of immune recognition 2 contributes to B7-2 downregulation.

Authors:  Mizuho Kajikawa; Pai-Chi Li; Eiji Goto; Naoyuki Miyashita; Masami Aoki-Kawasumi; Mari Mito-Yoshida; Mika Ikegaya; Yuji Sugita; Satoshi Ishido
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Construction and characterization of an infectious murine gammaherpesivrus-68 bacterial artificial chromosome.

Authors:  Ting-Ting Wu; Hsiang-I Liao; Leming Tong; Ronika Sitapara Leang; Greg Smith; Ren Sun
Journal:  J Biomed Biotechnol       Date:  2010-12-09

Review 4.  Immune evasion by Kaposi's sarcoma-associated herpesvirus.

Authors:  Hye-Ra Lee; Stacy Lee; Preet M Chaudhary; Parkash Gill; Jae U Jung
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

Review 5.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

6.  Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64.

Authors:  Kyung-Soo Inn; Sun-Hwa Lee; Jessica Y Rathbun; Lai-Yee Wong; Zsolt Toth; Keigo Machida; Jing-Hsiung James Ou; Jae U Jung
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

7.  KSHV infection of B-cell lymphoma using a modified KSHV BAC36 and coculturing system.

Authors:  Hyosun Cho; Hyojeung Kang
Journal:  J Microbiol       Date:  2012-04-27       Impact factor: 3.422

8.  Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.

Authors:  Mandana Mansouri; Patrick P Rose; Ashlee V Moses; Klaus Früh
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus.

Authors:  Mandana Mansouri; Kasinath Viswanathan; Janet L Douglas; Jennie Hines; Jean Gustin; Ashlee V Moses; Klaus Früh
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

Review 10.  [Humanes herpesvirus 8 (HHV-8) and Kaposi sarcoma].

Authors:  C Lebbé
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.